-
1 Comment
Ramsay Générale de Santé SA is currently in a long term uptrend where the price is trading 3.3% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
Ramsay Générale de Santé SA's total revenue sank by 0.0% to $967M since the same quarter in the previous year.
Finally, its free cash flow grew by 503.0% to $223M since the same quarter in the previous year.
Based on the above factors, Ramsay Générale de Santé SA gets an overall score of 3/5.
Industry | Medical Care Facilities |
---|---|
Sector | Healthcare |
ISIN | FR0000044471 |
CurrencyCode | EUR |
Exchange | F |
Dividend Yield | 0.0% |
---|---|
Target Price | None |
PE Ratio | 20.6 |
Market Cap | 2B |
Beta | -0.03 |
Ramsay Générale de Santé SA operates hospitals in France. Its hospitals offer a range of services in the areas of anesthesia, oncology, cardiology, dermatology, gastroenterology, gynecology, maternity, nephrology, neurosurgery, obesity, ophthalmology, orthopedics, stomatology, pneumonology, psychiatry, radiology, and urology, as well as thoracic, vascular, and endovascular surgeries. The company was formerly known as Générale de Santé SA and changed its name to Ramsay Générale de Santé SA in December 2015. Ramsay Générale de Santé SA was founded in 1987 and is based in Paris, France. Ramsay Générale de Santé SA operates as a subsidiary of Ramsay Health Care Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for GD6.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024